Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8744822 | Clinical Microbiology and Infection | 2018 | 26 Pages |
Abstract
Considerable interindividual variability observed in the pharmacokinetics of fosfomycin signifies a risk for inadequate drug exposure in a significant proportion of the population. The current dosing regimen should therefore be reevaluated.
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
R.A. Wijma, B.C.P. Koch, T. van Gelder, J.W. Mouton,